Trial Profile
Phase I exploratory study of pemetrexed and vinflunine in patients with advanced urothelial cell carcinoma after prior platinum-containing chemotherapy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2017
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Vinflunine (Primary)
- Indications Urogenital cancer
- Focus Adverse reactions
- Acronyms VINTREX
- 02 Nov 2017 New trial record
- 28 Oct 2017 Results published in the Investigational New Drugs